{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T13:44:59Z","timestamp":1758635099882},"reference-count":25,"publisher":"Informa UK Limited","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia & Lymphoma"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.3109\/10428190903518345","type":"journal-article","created":{"date-parts":[[2010,6,18]],"date-time":"2010-06-18T15:34:19Z","timestamp":1276875259000},"page":"406-414","source":"Crossref","is-referenced-by-count":14,"title":["High rate and prolonged duration of complete remissions induced by rituximab, methotrexate, doxorubicin, cyclophosphamide, vincristine, ifosfamide, etoposide, cytarabine, and thalidomide (R-MACLO-IVAM-T), a modification of the National Cancer Institute 89-C-41 regimen, in patients with newly diagnosed mantle cell lymphoma"],"prefix":"10.1080","volume":"51","author":[{"given":"Izidore S.","family":"Lossos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter J.","family":"Hosein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Morgensztern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francine","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maricer P.","family":"Escal\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Gerald E.","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph D.","family":"Rosenblatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gail R.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2009,12,28]]},"reference":[{"key":"CIT0001","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Swerdlow SH","year":"2008","edition":"4"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1097\/CCO.0b013e32830b61c2"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.16.8435"},{"key":"CIT0004","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1200\/JCO.1998.16.12.3803","volume":"16","author":"Khouri IF","year":"1998","journal-title":"J Clin Oncol"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.01.1825"},{"key":"CIT0006","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/oxfordjournals.annonc.a059155","volume":"6","author":"Zucca E","year":"1995","journal-title":"Ann Oncol"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.4693273.x"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.08.133"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.05.019"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1097\/00001622-200109000-00005"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-10-117010"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24141"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1016\/S1535-6108(03)00028-X"},{"key":"CIT0014","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1200\/JCO.1996.14.3.925","volume":"14","author":"Magrath I","year":"1996","journal-title":"J Clin Oncol"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-03-1091"},{"key":"CIT0016","first-page":"1860","volume":"31","author":"Carbone PP","year":"1971","journal-title":"Cancer Res"},{"key":"CIT0017","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","volume":"17","author":"Cheson BD","year":"1999","journal-title":"J Clin Oncol"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4899-3115-3"},{"key":"CIT0019","volume-title":"Analysing survival data from clinical trials and observational studies","author":"Marubini E","year":"1996"},{"key":"CIT0020","volume-title":"Common Terminology Criteria for Adverse Events v3.0","author":"National Cancer Institute","year":"2003"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-06-095331"},{"issue":"1","key":"CIT0022","first-page":"121a","volume":"110","author":"Epner EM","year":"2007","journal-title":"Blood"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-03-147025"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2009.07626.x"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-03-145128"}],"container-title":["Leukemia & Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.3109\/10428190903518345","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T06:42:13Z","timestamp":1559198533000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.3109\/10428190903518345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,28]]},"references-count":25,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2010,2,12]]},"published-print":{"date-parts":[[2010,3]]}},"alternative-id":["10.3109\/10428190903518345"],"URL":"https:\/\/doi.org\/10.3109\/10428190903518345","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"value":"1042-8194","type":"print"},{"value":"1029-2403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,28]]}}}